The Latest Cardiac and Vascular News
Data from BIOFLOW-V Trial Presented at CRT and Published in JACC: Cardiovascular Interventions Reinforces Orsiro’s Ability to Outperform Abbott’s Xience NATIONAL HARBOR, Md., Feb. 24, 2020 /PRNewswire/ — BIOTRONIK today announced three-year data from the BIOFLOW-V trial, which was presented yesterday at the 2020 CRT Congress. The three-year follow-up data demonstrates consistently lower clinical […]
PARIS and BUELACH, Switzerland, May 21, 2019 /PRNewswire/ — Focusing on patients with small vessels, three-year outcomes of the BIO-RESORT randomized controlled trial (RCT) showed a significantly lower target lesion revascularization (TLR) rate and thus better efficacy of the Orsiro® drug-eluting stent1 (DES) in comparison to the Resolute Integrity DES.2 Prof. Clemens von Birgelen, Thoraxcentrum Twente, MST, Enschede, the […]
